Alendronate Sodium Tablets Usp

Upsher-Smith Labs Recalls Jantoven Warfarin Sodium Tablets Due To Mislabeled Bottles

usrecallnews.com — “Upsher-Smith Laboratories Inc. is recalling one lot (lot #284081) of Jantoven® Warfarin Sodium, USP, 3mg Tablets, an anticoagulant with an expiration date of September 2012. The company is initiating the recall as a precautionary measure after a single bottle labeled as Jantoven® Warfarin Sodium, USP, 3mg Tablets was found to contain tablets at a higher, 10mg strength before it was dispensed.” View full resource at usrecallnews.com

View Related
Share

Most Recently Shared on February 18, 2011 at 3:14 pm By:

usrecallnews Health News

Upsher-Smith Labs Recalls Jantoven Warfarin Sodium Tablets Due To Mislabeled Bottles http://f.ast.ly/VBJPc

EffRx receives FDA approval for BINOSTO to treat osteoporosis

news-medical.net — “EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.” View full resource at news-medical.net

View Related
Share

Most Recently Shared on March 15, 2012 at 4:26 am By:

News-Medical.Net Health News and Oncology

Oncology News: EffRx receives FDA approval for BINOSTO to treat osteoporosis: EffRx Pharmaceuticals SA today ann... http://t.co/oNs9QvFc

2 months ago...

MNT Bones/Orthopedic Health News

EffRx Pharmaceuticals SA Announces Submission Of New Drug Application To FDA For Osteoporosis Treatment Targeting Increased Convenience For Patients

medicalnewstoday.com — “EffRx Pharmaceuticals SA, a Lausanne, Switzerland based drug delivery company announces the NDA submission of the company's lead project to the US Food and Drug Administration. EX101 is a” View full resource at medicalnewstoday.com

View Related
Share

Most Recently Shared on January 12, 2011 at 1:05 pm By:

EffRx Pharmaceuticals SA Announces Submission Of New Drug Application To FDA For Osteoporosis Treatment Targeting Incr... http://mnt.to/3PSM

Ohio Family Practice Physician Group

Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall. Affected Products Include Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantoven® and Oxybutynin

fda.gov — “Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets to include additional products that were packaged on the same packaging line between May 17, 2010 and November 17, 2010. The company is initiating the recall as a precautionary measure after a bottle labeled as Jantoven® Warfarin Sodium, USP, 3 mg Tablets was found by a retail pharmacy to contain tablets at a higher, 10 mg str” View full resource at fda.gov

View Related
Share

Most Recently Shared on February 19, 2011 at 6:22 pm By:

Drug recall expanded to include: Amantadine, Amlodipine, Baclofen, Bethanechol, JantovenÂ® and Oxybutynin http://goo.gl/5hQnK

Upsher-Smith Labs Announces Expansion of Nationwide Recall on Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantovena and Oxybutynin

usrecallnews.com — “Upsher-Smith Laboratories, Inc., is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets. The tablets were found by a retail pharmacy to contain tablets at a higher, 10 mg strength.” View full resource at usrecallnews.com

View Related
Share

Most Recently Shared on February 21, 2011 at 3:09 pm By:

usrecallnews Health News

Upsher-Smith Labs Announces Expansion of Nationwide Recall on Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, http://f.ast.ly/qebTD